Royal Bank of Canada’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2K Buy
+3,471
New +$3.2K ﹤0.01% 6776
2025
Q4
Sell
-196
Closed 7723
2025
Q3
$0 Sell
196
-93
-32% -$121 ﹤0.01% 7591
2025
Q2
$0 Sell
289
-927
-76% -$1.5K ﹤0.01% 7403
2025
Q1
$2K Sell
1,216
-2,321
-66% -$3.71K ﹤0.01% 6604
2024
Q4
$7K Sell
3,537
-2,900
-45% -$6.75K ﹤0.01% 6464
2024
Q3
$17K Buy
6,437
+5,730
+810% +$18.7K ﹤0.01% 6163
2024
Q2
$3K Buy
+707
New +$4.55K ﹤0.01% 6682

Other funds holding GUTS

Royal Bank of Canada's GUTS Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Fractyl Health (GUTS) in Q1 2026: 3,471 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #6776 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in GUTS as recently as Q3 2025.

Royal Bank of Canada first reported a position in GUTS in Q2 2024 and has held it in 7 quarters since. The position peaked at $17K in Q3 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Royal Bank of Canada held 3,471 shares of Fractyl Health worth $2K as of Q1 2026.
  • Fractyl Health was a new Royal Bank of Canada position in Q1 2026.
  • Fractyl Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6776 holding.
  • Royal Bank of Canada first reported a position in Fractyl Health in Q2 2024 and has held it in 7 quarters since.
  • Royal Bank of Canada's Fractyl Health position peaked at $17K in Q3 2024.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.